Pilot Study Testing Feasibility of Health Screening at Farm Site

NCT ID: NCT02418637

Last Updated: 2016-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Test the feasibility of performing worksite screening of Hypertension, Diabetes and Hyperlipidemia for six months

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will be visiting farmers at the worksite monthly for six month and perform cardiovascular risk factors screening: blood pressure, blood glucose, glycosylated hemoglobin and cholesterol.

At the end of this intervention, the investigators will test the feasibility of this approach among this specific population through questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Screening Hyperlipidemia Screening Hypertension Screening

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

worksite screen migrant agricultural worker hypertension Hyperlipidemia diabetes feasibility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Farm workers

This is a one arm intervention including farm workers and owners

Group Type EXPERIMENTAL

Worksite screening for DM, HTN and hyperlipidemia

Intervention Type OTHER

Six monthly visits to worksite to perform screenings

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Worksite screening for DM, HTN and hyperlipidemia

Six monthly visits to worksite to perform screenings

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older
* agricultural workers and farm owners

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

M. Hassan Murad, M.D.

PI

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

M Murad, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Rajjo T, Mohammed K, Rho J, Murad MH. On-the-farm cardiovascular risk screening among migrant agricultural workers in Southeast Minnesota: a pilot prospective study. BMJ Open. 2018 Jul 30;8(7):e019547. doi: 10.1136/bmjopen-2017-019547.

Reference Type DERIVED
PMID: 30061429 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-000647

Identifier Type: -

Identifier Source: org_study_id